Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Keizo Taniguchi is a pioneering surgeon at the forefront of robotic and minimally invasive oncologic surgery, with a primary focus on gastric cancer and complex peritoneal malignancies. His seminal 2011 work, "Robot-Assisted Surgery for Gastric Cancer: Experience at Our Institute" (46 citations), established foundational techniques for overcoming the limitations of conventional laparoscopy, demonstrating that robotic systems could enhance precision in gastric resections. Building on this, his 2023 study on Indocyanine Green (ICG) tracer-guided radical robotic distal gastrectomy using the Firefly™ system (13 citations) represents a major contribution to surgical oncology, showing how real-time fluorescence imaging significantly improves the quality and completeness of lymph node dissection—a critical factor in gastric cancer prognosis. Most recently, Dr. Taniguchi has pushed boundaries with a 2024 pilot study on robot-assisted cytoreductive surgery with upper-abdominal peritonectomy for pseudomyxoma peritonei (2 citations), exploring the feasibility of robotic approaches for patients with low peritoneal carcinomatosis indices. His work collectively demonstrates that robotic surgery can achieve superior oncologic outcomes while maintaining minimally invasive benefits, positioning him as a leader in translating advanced technology into tangible improvements in cancer surgery.